CARBOFLO VASCULAR GRAFT F5006SC

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,consum report with the FDA on 2016-10-28 for CARBOFLO VASCULAR GRAFT F5006SC manufactured by Bard Peripheral Vascular, Inc..

Event Text Entries

[58815876] No medical records or medical images have been made available to the manufacturer. As the lot number for the device was provided, a review of the device history records is currently being performed. The device has not been returned to the manufacturer for evaluation. The investigation of the reported event is currently underway. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[58815877] It was reported that the vascular graft material was allegedly tearing during the procedure. There was no reported patient injury.
Patient Sequence No: 1, Text Type: D, B5


[63933883] Manufacturing review: the device history records have been reviewed with special attention to the subassemblies, material review reports, raw material testing, manufacturing process, and quality control inspection. This lot met all release criteria. There was nothing found to indicate there was a manufacturing related cause for this event. This is the only complaint that has been reported for this corporate lot number to date. Visual inspection: the graft had some fluid located on the returned segment. The graft segment had two blue lines running longitudinally down the graft segment and had carbon lining, which identified the product as a bard graft. The segment measure 4. 0 cm in length. The beading was intact and present along the returned segment. It appears that both ends of the returned graft were cut. No holes, tears, or sutures were identified on the returned segment of graft. Dimensional evaluation: the graft measured approximately 4. 0 cm long. This measurement was not within specification. 46 cm of graft was not returned for evaluation. Medical records review: medical records were not provided; therefore, a review could not be performed. Image/photo review: images/photos were not provided; therefore, a review could not be performed. Conclusion: the investigation was inconclusive, as the returned graft segment had no holes, tears, or splits. However, the entirety of the graft was not returned for evaluation. The root cause could not be determined based upon available information. It was unknown whether procedural factors contributed to the event. Labeling review: the current instruction for use (ifu) states: eptfe grafts do not stretch (are non-elastic) in the longitudinal direction. The correct graft length for each procedure must be determined by considering the patient's body weight, posture, and the range of motions across the anatomical area of graft implantation. Failure to cut the graft to an appropriate length may result in anastomotic or graft disruption, leading to excessive bleeding, and loss of limb or limb function, and/or death. Aggressive and/or excessive graft manipulation when tunneling, or placement within a too tight or too small tunnel, may lead to separation of the spiral beading and/or graft breakage. When suturing, avoid excessive tension on the suture line, inappropriate suture spacing and bites, and gaps between the graft and host vessel. Failure to follow correct suturing techniques may result in suture hole elongation, suture pull-out, anastomotic bleeding and/or disruption. Additional mfr narrative: date received by mfr. Device available for evaluation? , device evaluated by mfr? , (b)(4). The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[63933884] It was reported that the vascular graft material was allegedly tearing during the procedure. There was no reported patient injury.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2020394-2016-01012
MDR Report Key6063561
Report SourceCOMPANY REPRESENTATIVE,CONSUM
Date Received2016-10-28
Date of Report2016-10-03
Date of Event2016-09-28
Date Mfgr Received2016-12-09
Device Manufacturer Date2015-07-06
Date Added to Maude2016-10-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJUDITH LUDWIG
Manufacturer Street1625 W 3RD ST.
Manufacturer CityTEMPE AZ 85281
Manufacturer CountryUS
Manufacturer Postal85281
Manufacturer Phone4803032689
Manufacturer G1BARD PERIPHERAL VASCULAR, INC.
Manufacturer Street1625 W 3RD ST.
Manufacturer CityTEMPE AZ 85281
Manufacturer CountryUS
Manufacturer Postal Code85281
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCARBOFLO VASCULAR GRAFT
Generic NameEPTFE VASCULAR GRAFT
Product CodeDYF
Date Received2016-10-28
Returned To Mfg2016-11-07
Catalog NumberF5006SC
Lot NumberVTZF0680
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBARD PERIPHERAL VASCULAR, INC.
Manufacturer Address1625 W 3RD ST. TEMPE AZ 85281 US 85281


Patients

Patient NumberTreatmentOutcomeDate
10 2016-10-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.